• Home
  • Licensing
  • Browse All

All Available Technologies

KU research on the brain activity associated with low back pain led to the invention of a simple and cost-effective device that can be used to induce stimulation to a person's back during an fMRI scanning procedure.

Subcategory(s):

Novel Cyclophilin D inhibitors to treat Alzheimer's and other neurodegenerative diseases.

Category(s):
Subcategory(s):

This invention comprises of an aircraft that is capable of both sustained out-of-ground effect hover flight and sustained supersonic flight

Category(s):
Subcategory(s):

This invention comprises of an apparatus and method for adaptive materials that are arranged in a variety of orientations and with a wide range of attachment configurations that induce structural vibrations at extremely high frequencies.

Category(s):
Subcategory(s):

This invention provides a computationally efficient means of performing adaptive pulse compression (APC) and is denoted as the Fast APC (FAPC) algorithm. The FAPC algorithm dramatically reduces range sidelobes while maintaining near optimal signal-to-noise (SNR) gain and is much more computationally efficient than the original APC.

Category(s):
Subcategory(s):

A novel method of inducing adult-derived stem cell proliferation in tissue from adult animals. Harvested embryonic, pluripotent or more differentiated stem cells may be used in cell therapy, tissue engineering, or other medical, veterinary, and industrial applications.

Category(s):
Subcategory(s):

Novel chemical compounds for use as antivirals against VEEV and other alpha viruses.

Method of restoring hair and treating baldness by using cell culture systems and inducing mesenchymal cells to differentiate into CK19-positive cells capable of regenerating hair.

Subcategory(s):
Small molecule compounds that act as vaccine adjuvants by specifically binding to Toll-Like Receptor-2 (TLR2).  
Category(s):

Conjugate compositions that combine a functionalized I-domain peptide covalently bound to multiple signal-1 blocking moieties to reduce type-1 immune responses.

Category(s):
Subcategory(s):

Pages


Events
KU Today